Startups channel feed – Endpoints News

Startups channel feed

With $270M, Beam spinoff Orbital Therapeutics builds RNA medicines as it hunts for partners, more delivery tech

3 years ago

Pfizer-backed Vedanta Biosciences lands $106M for PhIII in C. diff, PhII in IBD

3 years ago

VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year

3 years ago

Herceptin founder snags $158M for his UCLA-biotech partnership TORL BioTherapeutics

3 years ago

Briggs Morrison helms new MPM oncology startup with Pfizer Ventures, Polaris partners on board

3 years ago

Acelyrin files to go public in rare sign of biotech IPO

3 years ago

Pyramid inks TROP2 pact with China biotech to follow suit of Gilead, AstraZeneca-Daiichi Sankyo

3 years ago

Trio of VCs launches Gaelic-inspired Aer Therapeutics with $36M to prove itself in COPD around 2025

3 years ago

Biopharma venture funding falls to the lowest total since 2019 as startups ponder alternative paths

3 years ago

Novo Nordisk taps into Canadian biotech’s cell therapies for diabetes and obesity in deal worth up to $2.6B

3 years ago

A new cell therapy biotech emerges to find solid tumor-killing immune cells in patients' blood

3 years ago

Canaan lands $650M for latest VC fund aimed at tech and drug development

3 years ago

Proxygen and Merck strike license deal worth up to $2.55B for protein degradation

3 years ago

OnKure Therapeutics nabs $60M as HDAC inhibitor awaits solid-tumor readouts

3 years ago

Exclusive: Oncology startup from Sanger Institute nabs $28M, ex-Novartis SVP as CEO

3 years ago

Mitochondria biotech field grows as RA, Insight up the Capacity with a new $35M startup

3 years ago

BioNTech delves into ADCs with $170M upfront weeks after Pfizer lines up Seagen

3 years ago

Mathai Mammen hands in J&J's R&D keys to lead Greg Verdine’s FogPharma

3 years ago

Portal Innovations takes its Chicago biotech investing, lab space model to Boston with Bob Langer startup in tow

3 years ago

Tiny multiomics biotech secures former J&J drug, new execs and new financing

3 years ago

With Boehringer Ingelheim’s help, Roivant churns out another Vant to go up against Endeavor, Impact founders

3 years ago

Labviva nets $20M Series A to ease life science procurement process

3 years ago

With one of biotech's largest private rounds in a year, ArriVent enters PhIII

3 years ago

Gilead passes on fully acquiring Pionyr, as eyes now turn to Tizona, a fellow summer 2020 buyout option

3 years ago

First page Previous page 30 31 323334 35 36 Next page Last page